Able C&C Co., Ltd. (KRX:078520)
South Korea · Delayed Price · Currency is KRW 11,630
+80 (0.69%)
At close: Apr 8, 2026
Able C&C Revenue
In the year 2025, Able C&C had annual revenue of 242.00B KRW with 1.15% growth.
Revenue
242.00B
Revenue Growth
+1.15%
P/S Ratio
1.23
Revenue / Employee
1.01B
Employees
240
Market Cap
297.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 242.00B | 2.76B | 1.15% |
| Dec 31, 2024 | 239.24B | -34.40B | -12.57% |
| Dec 31, 2023 | 273.65B | 25.77B | 10.40% |
| Dec 31, 2022 | 247.87B | -15.07B | -5.73% |
| Dec 31, 2021 | 262.95B | -44.57B | -14.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aekyung Industrial | 654.53B |
| Kolmar Holdings | 630.11B |
| KOLMAR BNH | 574.88B |
| VT Co., Ltd. | 437.18B |
| Tonymoly | 220.27B |
| It'S Hanbul | 153.39B |
| Monalisa | 140.89B |
| NeoPharm CO., LTD. | 132.18B |